ATP7B antisense oligodeoxynucleotides increase the cisplatin sensitivity of human ovarian cancer cell line SKOV3ipl

International Journal of Gynecological Cancer

Volumn 18, Issue 4, 2008, Pages 718-722

  Xu, W ^a   Cai, B ^a   Chen, J L ^a   Li, L X ^a   Zhang, J R ^a   Sun, Y Y ^a   Wan, X P ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Antisense oligodeoxynucleotide; ATP7B; Cisplatin; SKOV3ip1

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CISPLATIN; LIPOFECTAMINE; MESSENGER RNA; WILSON DISEASE PROTEIN ANTISENSE OLIGODEOXYNUCLEOTIDE;

ARTICLE; CANCER CELL CULTURE; CELL STRAIN SKOV3IPL; CONTROLLED STUDY; DRUG SENSITIVITY; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IC 50; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; TREATMENT OUTCOME; WESTERN BLOTTING;

ADENOSINE TRIPHOSPHATASES; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CATION TRANSPORT PROTEINS; CELL LINE, TUMOR; CISPLATIN; DRUG EVALUATION, PRECLINICAL; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; OVARIAN NEOPLASMS; RNA, MESSENGER; TRANSFECTION;

EID: 47649084216     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2007.01085.x     Document Type: Article

References (22)

1. Andrews PA, Jones JA, Varki NM, Howell SB. Rapid emergence of acquired cisdiamminedichloroplatinum(II) resistance in an in vivo model of human ovarian carcinoma. Cancer Commun 1990 2 : 93 100.
2. Kuo MT, Chen HH, Song IS, Savaraj N, Ishikawa T. The roles of copper transporters in cisplatin resistance. Cancer Metastasis Rev 2007 26 : 71 83.
3. Safaei R. Role of copper transporters in the uptake and efflux of platinum containing drugs. Cancer Lett 2006 234 : 34 9.
4. Katano K, Kondo A, Safaei R et al. Acquisition of resistance to cisplatin is accompanied by changes in the cellular pharmacology of copper. Cancer Res 2002 62 : 6559 65.
5. Aida T, Takebayashi Y, Shimizu T et al. Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) as a prognostic factor in human endometrial carcinoma. Gynecol Oncol 2005 97 : 41 5.
6. Katoh R, Takebayashi Y, Takenoshita S. Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) as a chemoresistance marker in human solid carcinomas. Ann Thorac Cardiovasc Surg 2005 11 : 143 5.
7. Sugeno H, Takebayashi Y, Higashimoto M et al. Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) in human hepatocellular carcinoma. Anticancer Res 2004 24 : 1045 8.
8. Nakayama K, Miyazaki K, Kanzaki A, Fukumoto M, Takebayashi Y. Expression and cisplatin sensitivity of copper-transporting P-type adenosine triphosphatase (ATP7B) in human solid carcinoma cell lines. Oncol Rep 2001 8 : 1285 7.
9. Safaei R, Howell SB. Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugs. Crit Rev Oncol Hematol 2005 53 : 13 23.
10. Komatsu M, Sumizawa T, Mutoh M et al. Copper-transporting P-type adenosine triphosphatase (ATP7B) is associated with cisplatin resistance. Cancer Res 2000 60 : 1312 6.
11. Katano K, Safaei R, Samimi G, Holzer A, Rochdi M, Howell SB. The copper export pump ATP7B modulates the cellular pharmacology of carboplatin in ovarian carcinoma cells. Mol Pharmacol 2003 64 : 466 73.
12. Kanzaki A, Toi M, Neamati N et al. Copper-transporting P-type adenosine triphosphatase (ATP7B) is expressed in human breast carcinoma. Jpn J Cancer Res 2002 93 : 70 7.
13. Nakayama K, Kanzaki A, Ogawa K, Miyazaki K, Neamati N, Takebayashi Y. Copper-transporting P-type adenosine triphophatase (ATP7B) as a cisplatin-based chemoresistance marker in ovarian carcinoma: comparative analysis with expression of MDR1, MRP, LRP and BCRP. Int J Cancer 2002 101 : 488 95.
14. Ohbu M, Ogawa K, Konno S et al. Copper-transporting P-type adenosine triphosphatase (ATP7B) is expressed in human gastric carcinoma. Cancer Lett 2003 189 : 33 8.
15. Miyashita H, Nitta Y, Mori S et al. Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) as a chemoresistance marker in human oral squamous cell carcinoma treated with cisplatin. Oral Oncol 2003 39 : 157 62.
16. Higashimoto M, Kanzaki A, Shimakawa T et al. Expression of copper-transporting P-type adenosine triphosphatase in human esophageal carcinoma. Int J Mol Med 2003 11 : 337 41.
17. Summerton J. Morpholino antisense oligomers: the case for an RNase H-independent structural type. Biochim Biophys Acta 1999 1489 : 141 58.
18. Kyhse-Anderson J. Electroblotting of multiple gels: a simple apparatus without buffer tank for rapid transfer of proteins from polyacrylamide to nitrocellulose. J Biochem Biophys Methods 1984 10 : 203 9.
19. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 1987 47 : 936 42.
20. Chen ZS, Mutoh M, Sumizawa T et al. An active efflux system for heavy metals in cisplatin-resistant human KB carcinoma cells. Exp Cell Res 1998 240 : 312 20.
21. Safaei R, Holzer AK, Katano K, Samimi G, Howell SB. The role of copper transporters in the development of resistance to Pt drugs. J Inorg Biochem 2004 98 : 1607 13.
22. Nakayama K, Kanzaki A, Terada K et al. Prognostic value of the Cu-transporting ATPase in ovarian carcinoma patients receiving cisplatin-based chemotherapy. Clin Cancer Res 2004 10 : 2804 11.